Genetic control of Bordetella pertussis infection: Identification of susceptibility loci using recombinant congenic strains of mice

Infection and Immunity

Volumn 73, Issue 2, 2005, Pages 741-747

  Banus, H A ^a   Van Kranen, H J ^a   Mooi, F R ^a   Hoebee, B ^a   Nagelkerke, N J ^a   Demant, P ^b   Kimman, T G ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; BORDETELLA PERTUSSIS; BPS 1 GENE; BPS 2 GENE; BPS 3 GENE; CCS GENE; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 5; CONGENIC STRAIN; DEATH; FEMALE; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENETIC MARKER; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENOME; GENOTYPE; HCB GENE; HUMAN; INFECTION CONTROL; LINKAGE ANALYSIS; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL;

ANIMALS; BORDETELLA PERTUSSIS; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; LINKAGE (GENETICS); LOD SCORE; LUNG; MICE; MICE, CONGENIC; WHOOPING COUGH;

EID: 12844286185     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.2.741-747.2005     Document Type: Article

References (36)

1. Badalova, J., M. Svobodova, H. Havelkova, V. Vladimirov, J. Vojtiskova, J. Engova, T. Pilcik, P. Volf, P. Demant, and M. Lipoldova. 2002. Separation and mapping of multiple genes that control IgE level in Leishmania major infected mice. Genes Immun. 3:187-195.
2. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
3. Belcher, C. E., J. Drenkow, B. Kehoe, T. R. Gingeras, N. McNamara, H. Lemjabbar, C. Basbaum, and D. A. Relman. 2000. The transcriptional responses of respiratory epithelial cells to Bordetella pertussis reveal host defensive and pathogen counter-defensive strategies. Proc. Natl. Acad. Sci. USA 97:13847-13852.
4. Cherry, J. D. 1999. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28(Suppl.)2:S112-S117.
5. Churchill, G. 2004. QTL mapping overview. [Online.] http://www.jax.org /staff/churchill/labsite/research/qtl/. Accessed 13 April 2004.
6. Demant, P. 1992. Genetic resolution of susceptibility to cancer-new perspectives. Semin. Cancer Biol. 3:159-166.
7. Demant, P. 2003. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat. Rev. Genet. 4:721-734.
8. Demant, P., and A. A. Hart. 1986. Recombinant congenic strains-a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24:416-422.
9. Frankel, W. N. 1995. Taking stock of complex trait genetics in mice. Trends Genet. 11:471-477.
10. Frankel, W. N., and N. J. Schork. 1996. Who's afraid of epistasis? Nat. Genet. 14:371-373.
11. Groot, P. C., C. J. Moen, W. Dietrich, J. P. Stoye, E. S. Lander, and P. Demant. 1992. The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J. 6:2826-2835.
12. Hellwig, S. M., H. F. van Oirschot, W. L. Hazenbos, A. B. van Spriel, F. R. Mooi, and J. G. van de Winkel. 2001. Targeting to Fcγ receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J. Infect. Dis. 183:871-879.
13. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, p. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171:3119-3127.
14. Kimman, T. 2001. Genetics of infectious disease susceptibility. Kluwer Academic Publishers, Dordrecht, The Netherlands.
15. King, A. J., G. Berbers, H. F. van Oirschot, P. Hoogerhout, K. Knipping, and F. R. Mooi. 2001. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology 147:2885-2895.
16. Kramnik, I., P. Demant, and B. B. Bloom. 1998. Susceptibility to tuberculosis as a complex genetic trait: analysis using recombinant congenic strains of mice. Novartis Found. Symp. 217:120-131.
17. Kramnik, I., W. F. Dietrich, P. Demant, and B. R. Bloom. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 97:8560-8565.
18. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241-247.
19. Lander, E. S., and N. J. Schork. 1994. Genetic dissection of complex traits. Science 265:2037-2048.
20. Lipoldova, M., M. Svobodova, M. Krulova, H. Havelkova, J. Badalova, E. Nohynkova, V. Holan, A. A. Hart, P. Volf, and P. Demant. 2000. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun. 1:200-206.
21. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. Mills. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J. Exp. Med. 186:1843-1851.
22. Mann, P. B., M. J. Kennett, and E. T. Harvill. 2004. Toll-like receptor 4 is critical to innate host defense in a murine model of bordctellosis. J. Infect. Dis. 189:833-836.
23. Massachusetts Institute of Technology. 2004. Look up STSs by name. [Online.] http://www.broad.mit.edu/cgi-bin/mousc/sts_info?database=mouserelease. Accessed 28 April 2004.
24. Mattoo, S., A. K. Foreman-Wykert, P. A. Cotter, and J. F. Miller. 2001. Mechanisms of Bordetella pathogenesis. Front. Biosci. 6:E168-E186.
25. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
26. Mooi, F. R., I. H. Van Loo, and A. J. King. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526-528.
27. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. van der Heide, W. Gaastra, and R. J. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675.
28. Mouse Genome Informatics. 2004. Recombinant congenic strain distribulion patterns query form. [Online.] http://www.informatics.jax.org/scarches/ rcsetb_form.shtml. Accessed 28 April 2004.
29. Nadeau, J. H. 2001. Modifier genes in mice and humans. Nat. Rev. Genet. 2:165-174.
30. Nickerson, C. A. 2001. Altered gene expression in response to Bordetella pertussis infection. Trends Microbiol. 9:57-58.
31. Stassen, A. P., P. C. Groot, J. T. Eppig, and P. Demant. 1996. Genetic composition of the recombinant congenic strains. Mamm. Genome 7:55-58.
32. Tanaka, M., C. R. Vitek, F. B. Pascual, K. M. Bisgard, J. E. Tate, and T. V. Murphy. 2003. Trends in pertussis among infants in the United States, 1980-1999. JAMA 290:2968-2975.
33. Venvey, W. F., E. H. Thiele, D. N. Sage, and L. T. Suchardt. 1949. A simplified liquid culture medium for the growth of Haemophilus pertussis. J. Bacteriol. 58:127-134.
34. Vladimirov, V., J. Badalova, M. Svobodova, H. Havelkova, A. A. Hart, H. Blazkova, P. Demant, and M. Lipoldova. 2003. Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice. Infect. Immun. 71:2041-2046.
35. Willems, R. J., J. Kamerbeek, C. A. Geuijen, J. Top, H. Gielen, W. Gaastra, and F. R. Mooi. 1998. The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model. Vaccine 16:410-416.
36. World Health Organization. 2003. Pertussis vaccine. [Online.] http://www.who.int/vaccines/en/pertussis.shtml. Accessed 17 Oct. 2003.